Multiparametric 18F-FDG PET/MRI based on restrictive spectrum imaging and amide proton transfer-weighted imaging facilitates the assessment of lymph node metastases in non-small cell lung cancer
Author Block: N. Meng1, X. Liu1, J. Pan1, X. Yu1, Y. Wu1, Y. Yang2, Z. Wang3, M. Wang1; 1Zhengzhou/CN, 2Bei Jing/CN, 3Shanghai/CN
Purpose: To investigate the value of multiparametric 18F-FDG PET/MRI based on tri-compartmental restrictive spectrum imaging (RSI), amide proton transfer-weighted imaging (APTWI), and diffusion-weighted imaging (DWI) in the assessment of lymph node metastases (LNM) of non-small cell lung cancer (NSCLC)
Methods or Background: A total of 152 NSCLC patients were enrolled. 18F-FDG PET- derived parameter (SUVmax), RSI-derived parameters (f1, f2, and f3), APTWI-derived parameter (MTRasym(3.5ppm)), DWI-derived parameter (ADC), and were calculated. Logistic regression analysis was used to identify independent predictors, and combined diagnostics. AUC, calibration curves and decision curve analysis (DCA) were employed to assess the performance of the combined diagnostics.
Results or Findings: MTRasym(3.5ppm), SUVmax, f2, and f3 were higher and ADC and f1 were lower in LNM-positive group than in LNM-negative group (all P < 0.05). Maximum lesion diameter, f1, MTRasym(3.5ppm) , SUVmax, and ADC were independent predictors of LNM status in NSCLC patients, and the combination of them had an optimal diagnostic efficacy (AUC = 0.978; sensitivity = 95.35 %; specificity = 90.91 %), which was significantly higher than maximum lesion diameter, f1, MTRasym(3.5ppm), SUVmax, and ADC (AUC = 0.774, 0.810, 0.832, 0.834, and 0.783, respectively, and all P < 0.01). The combined diagnosis showed a good performance (AUC = 0.968) in the bootstrap (1000 samples)-based internal validation. Calibration curves and DCA demonstrated that the combined diagnosis not only provided better stability, but also resulted in a higher net benefit for the patients involved.
Conclusion: Multiparametric 18F-FDG PET/MRI based on RSI, APTWI, and DWI is beneficial for the non-invasive assessment of LNM status in NSCLC, and the combination of maximum diameter, f1, MTRasym(3.5ppm), SUVmax, and ADC may serve as a promising biomarker.
Limitations: This study was conducted at a single institution with a relatively small sample size
Funding for this study: The National Key R&D Program of China (2023YFC2414200), the National Natural Science Foundation of China (82371934), the Joint Fund of Henan Province Science and Technology R&D Program (225200810062).
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: The current study received approval from the local ethics committee, and all participants provided written informed consent for participation.